Measured
YC W21New York City, US · Founded 2021 · 12 employees · Hiring · 3 known investors
Measured provides telehealth-based weight loss and metabolic health treatment using GLP-1 medications, supported by physicians and health coaches. The service targets individuals with obesity and chronic disease in the U.S. through personalized, science-backed treatment plans.
Also known as Better Health Labs · Measured Health · Try Measured
Founders & leadership· Y Combinator alumni (W21)
Measured was founded in 2021 by Monji Dolon.
Investors · 3
Company profile
researched Aug 2026Measured is a US telemedicine service for weight loss, metabolic health and longevity care. Patients complete an online eligibility quiz covering medical history, lifestyle and goals, after which a licensed, board-certified provider reviews the information — sometimes alongside lab work — and builds a personalized treatment plan that may combine prescription medication, nutrition guidance and behavioral support. Prescriptions are filled by independent, state-licensed pharmacies and shipped to the patient's home, with follow-up handled through secure telehealth. The company states it is LegitScript certified.
The medication catalog spans more than 14 options, including branded GLP-1 and GLP-1/GIP therapies (Wegovy, Ozempic, Zepbound, Mounjaro and an oral Wegovy pill), compounded semaglutide and tirzepatide, and a lower-dose "GLP-1 microdose" regimen. Measured has extended into longevity and wellness products such as NAD+ injections, sermorelin, B12 + MIC, glutathione and oxytocin nasal spray. Alongside medication, members receive an app for provider messaging, prescription management and progress tracking, 1:1 registered dietitian coaching with meal guides, biomarker and lab insights, and access to a private member community. The company discloses that compounded medications are not FDA-approved or evaluated for safety and effectiveness, and that results vary.
Founding story
Measured was founded in 2021 and participated in Y Combinator's Winter 2021 batch. Its founder and CEO writes that the company grew out of personal and family experience with weight struggles and the effects of obesity, and the difficulty of navigating treatment alone, leading to a program built around individualized, science-backed plans supported by doctors and health coaches.
Business model
Direct-to-consumer subscription telehealth. Membership starts at $49 per month and can be canceled at any time; some plans bundle medication into the monthly price (for example compounded semaglutide from $119/mo, compounded tirzepatide from $219/mo, GLP-1 microdose from $79/mo, NAD+ from $159/mo) while branded medications are billed separately, either through insurance or cash pay ($149–$449/mo depending on the drug). Memberships are HSA/FSA eligible and the company handles insurance submission and prior authorization on the patient's behalf. Prescriptions are dispensed by independent third-party pharmacies rather than by Measured itself.
Recurring monthly membership fees starting at $49/mo, plus medication revenue on plans where the drug is included in the subscription price; branded GLP-1 medications are paid for separately by the patient or their insurer.
Traction
The company reports more than 51,000 members, a private community of over 10,000 members, a 4.9-star customer rating, and a team of 12. Y Combinator's profile describes thousands of customers across the US and rapid growth.
Latest developments
Measured has introduced a longevity-focused offering built around GLP-1 microdosing, metabolic optimization, inflammation reduction and cardiovascular health, and has launched NAD+ injections as a new product, alongside sermorelin, B12 + MIC, glutathione and oxytocin nasal spray. It also offers the oral Wegovy pill and reports passing 51,000 members. The company states it is backed by investors including Scott Galloway and Michael Seibel, and is hiring for clinical, insurance and patient-support roles.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Operates in the direct-to-consumer GLP-1 telehealth category, positioning itself as a full metabolic health home rather than a medication-only provider, with both insurance-covered branded GLP-1s and lower-cost compounded alternatives. It reports over 51,000 members and says it supports coverage across 75% of the country.
Breadth of medication options (14+, spanning branded, compounded and microdose GLP-1s) with support both with and without insurance, combined with included clinical wraparound care — obesity-trained providers, registered dietitians and care coordinators with unlimited messaging — plus lab and biomarker interpretation and an expanding longevity and wellness product line.
Technology
A consumer telehealth stack combining an online medical intake and eligibility quiz, asynchronous and secure telehealth consultations with licensed providers, a mobile app for provider messaging, prescription management and progress tracking, nutrition and habit-support content, and lab/biomarker reporting. Fulfillment is routed to independent state-licensed pharmacies.
Go-to-market
Online direct-to-consumer acquisition anchored on a 2-minute eligibility quiz that routes prospects into weight loss, longevity or metabolic health programs, supported by customer testimonials, before-and-after results and a 4.9-star review rating. Retention is driven by a dedicated care team (provider, registered dietitian, care coordinator), unlimited messaging, an app and a private member community.
US adults seeking weight loss, metabolic health or longevity treatment, including people with obesity and related chronic conditions; the company cites roughly 100 million US adults with obesity (42% of the adult population) as its addressable problem.
Geography
United States only, headquartered in New York City, with remote and multi-state clinical and support staffing (roles listed in New York and remote across states including Alabama, Florida and Georgia). The company cites nationwide access covering 75% of patients.
History
Founded in 2021 in New York City and part of Y Combinator's Winter 2021 batch, Measured built a telemedicine platform for chronic conditions such as obesity. It has since expanded from GLP-1 weight loss prescribing into insurance-covered branded GLP-1s, compounded and microdose regimens, and a longevity and wellness line including NAD+, sermorelin, B12 + MIC, glutathione and oxytocin nasal spray, while adding registered dietitian coaching, lab and biomarker testing and a member app.
Risks & controversies
A portion of prescribing involves compounded semaglutide and tirzepatide, which the company discloses are not reviewed or approved by the FDA for safety, effectiveness or quality — a regulatory-sensitive area for GLP-1 telehealth. Other operational exposures include reliance on independent third-party pharmacies for dispensing, dependence on insurance coverage and prior authorization for branded medications, and marketing claims about weight loss outcomes that are qualified by "results may vary."
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 3
by search overlap
Companies competing with Measured for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 2
launches, deals, and filingsMeasured added a longevity and wellness line including a newly launched NAD+ injection, sermorelin, B12 + MIC, glutathione and oxytocin nasal spray, alongside a lower-dose GLP-1 microdose program.
Measured, a telemedicine platform for chronic conditions such as obesity, was part of Y Combinator's Winter 2021 batch.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Measuredtrymeasured.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Measured do?
- Telemedicine platform offering GLP-1 weight loss, metabolic health and longevity treatment with provider and dietitian support.
- Who founded Measured?
- Measured was founded by Monji Dolon in 2021.
- Who are Measured's investors?
- Measured's investors include Open Opportunity Fund, Telescope Partners, Y Combinator.
- Where is Measured headquartered?
- Measured is headquartered in New York City, US.